Peter Altman Bio Cardia, Inc. (BCDA) insider trading activity

Peter Altman is President and CEO of BioCardia, Inc.. Currently has a direct ownership of 267,966 shares of BCDA, which is worth approximately $329,598. The most recent transaction as insider was on Dec 17, 2025, when has been sold 900 shares (Common Stock) at a price of $1.3 per share, resulting in proceeds of $1,170. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 268K

23.62% 3M change

151.42% 12M change

Total Value Held $329,598

Peter Altman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 17 2025	BUY Open market or private purchase	$1,170 $1.3 p/Share	900 Added 0.33%	267,966 Common Stock
Dec 16 2025	BUY Open market or private purchase	$274 $1.37 p/Share	200 Added 0.07%	267,066 Common Stock
Dec 08 2025	BUY Payment of exercise price or tax liability	$77,383 $1.37 p/Share	56,484 Added 17.47%	266,866 Common Stock
Dec 08 2025	BUY Grant, award, or other acquisition	$146,025 $1.37 p/Share	106,588 Added 24.79%	323,350 Common Stock
Sep 19 2025	BUY Open market or private purchase	$60,000 $1.25 p/Share	48,000 Added 18.13%	216,762 Common Stock
Aug 22 2025	BUY Open market or private purchase	$1,281 $1.83 p/Share	700 Added 0.41%	168,762 Common Stock
Aug 13 2025	BUY Open market or private purchase	$183 $1.83 p/Share	100 Added 0.06%	168,062 Common Stock

Aug 12 2025	BUY Open market or private purchase	$700 $1.75 p/Share	400 Added 0.24%	167,962 Common Stock
Aug 11 2025	BUY Open market or private purchase	$2,992 $1.76 p/Share	1,700 Added 1.0%	167,562 Common Stock
Jun 30 2025	BUY Open market or private purchase	$50,119 $2.08 p/Share	24,096 Added 12.68%	165,862 Common Stock
May 30 2025	BUY Open market or private purchase	$221 $2.21 p/Share	100 Added 0.07%	141,766 Common Stock
May 22 2025	BUY Open market or private purchase	$1,323 $1.89 p/Share	700 Added 0.49%	141,666 Common Stock
May 20 2025	BUY Open market or private purchase	$3,328 $2.08 p/Share	1,600 Added 1.12%	140,966 Common Stock
May 16 2025	BUY Open market or private purchase	$729 $2.43 p/Share	300 Added 0.21%	139,366 Common Stock
May 14 2025	BUY Open market or private purchase	$299 $2.99 p/Share	100 Added 0.07%	139,066 Common Stock
Apr 23 2025	BUY Open market or private purchase	$49,867 $1.9 p/Share	26,246 Added 15.89%	138,966 Common Stock
Apr 15 2025	BUY Open market or private purchase	$214 $2.14 p/Share	100 Added 0.09%	112,720 Common Stock
Apr 11 2025	BUY Open market or private purchase	$608 $2.03 p/Share	300 Added 0.27%	112,620 Common Stock
Apr 10 2025	BUY Open market or private purchase	$597 $1.99 p/Share	300 Added 0.27%	112,320 Common Stock
Apr 07 2025	BUY Open market or private purchase	$980 $1.96 p/Share	500 Added 0.44%	112,020 Common Stock
Apr 04 2025	BUY Open market or private purchase	$1,632 $2.04 p/Share	800 Added 0.71%	111,520 Common Stock
Apr 03 2025	BUY Open market or private purchase	$1,320 $2.2 p/Share	600 Added 0.54%	110,720 Common Stock
Apr 03 2025	BUY Open market or private purchase	$2,688 $2.24 p/Share	1,200 Added 1.08%	109,620 Common Stock
Apr 02 2025	BUY Open market or private purchase	$1,115 $2.23 p/Share	500 Added 0.45%	110,120 Common Stock
Mar 03 2025	BUY Open market or private purchase	$1,055 $2.11 p/Share	500 Added 0.46%	108,420 Common Stock

Peter Altman

President and CEO

Sunnyvale, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCDA shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Cardia, Inc. insider buys or sells BCDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioCardia, Inc.

Track Activities on BCDA

Account